Physician profile
Edward Burrus
NPI 1780656595
$979.03
in general payments reported to CMS, 2019-2025
13 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $303 · 2023: $281 · 2024: $221 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $676.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $506.99 | 2022-2025 | Puraply, Affinity, Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $99.87 | 2022 | |
| Mimedx Group, INC. | $71.38 | 2024-2025 | |
| Solventum Corporation | $69.38 | 2024-2025 | Activ.A.C., Promogran Prisma, V.A.C. Dermatac |
| Smith+Nephew, INC. | $56.93 | 2023-2024 | Grafix Pl |
| Hydrofera LLC | $33.29 | 2023-2024 | Hydrofera Blue, Hydrofera Blue Classic |
| Convatec INC. | $30.76 | 2022-2024 | |
| Bioventus LLC | $25.91 | 2022 | |
| Urgo Medical North America, LLC | $21.91 | 2024 | Urgoclean Ag |
| Next Science LLC | $20.47 | 2023 | Blastx, Surgx, Xperience |
| Kci USA, INC. | $15.13 | 2023 | Tegaderm, 3m Cavilon |
| Advanced Oxygen Therapy INC. | $13.89 | 2024 | Topical Oxygen Chamber For Extremities |
| Integra Lifesciences Corporation | $13.12 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Burrus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.